
Surgalign Holdings SRGA
Quarterly report 2023-Q1
added 05-11-2023
Surgalign Holdings Operating Expenses 2011-2026 | SRGA
Annual Operating Expenses Surgalign Holdings
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 120 M | 202 M | 136 M | 175 M | 134 M | 128 M | 136 M | 123 M | 123 M | 96.9 M | 70.6 M | 65.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 202 M | 65.4 M | 126 M |
Quarterly Operating Expenses Surgalign Holdings
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.4 M | - | 23.6 M | 27.6 M | 23.1 M | - | 34.6 M | 30.9 M | 31.5 M | - | 42.7 M | 36.2 M | 45.8 M | - | 41.6 M | 45.3 M | 45.4 M | - | 33.3 M | 37.4 M | 33.7 M | - | -780 K | 36.3 M | 38.2 M | - | 37.6 M | 36.7 M | 32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 45.8 M | -780 K | 33.5 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
59.6 M | $ 13.17 | 0.42 % | $ 1.78 B | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Eargo
EAR
|
126 M | - | - | $ 10.2 M | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 10.75 | 3.56 % | $ 385 M | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
40.3 M | $ 25.75 | 0.16 % | $ 218 M | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.11 | 3.19 % | $ 1.28 M | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.48 | 4.82 % | $ 130 M | ||
|
Inspire Medical Systems
INSP
|
240 M | $ 57.07 | 1.66 % | $ 1.68 B | ||
|
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
697 M | $ 61.31 | 2.01 % | $ 3.34 B | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 11.47 | 2.59 % | $ 325 M | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.62 | 2.05 % | $ 38.6 M | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.03 | - | $ 17.4 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.27 | 1.39 % | $ 358 M | ||
|
Sintx Technologies
SINT
|
11.2 M | $ 2.48 | 19.23 % | $ 6.88 M | ||
|
Butterfly Network
BFLY
|
123 M | $ 5.4 | 12.63 % | $ 1.14 B | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Stryker Corporation
SYK
|
11.2 B | $ 299.52 | -4.95 % | $ 114 B | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
547 M | $ 92.15 | 2.18 % | $ 12.5 B | ||
|
TransMedics Group
TMDX
|
254 M | $ 99.41 | -1.37 % | $ 3.38 B | ||
|
Tandem Diabetes Care
TNDM
|
159 M | $ 19.28 | -1.25 % | $ 1.31 B | ||
|
NanoVibronix
NAOV
|
23 M | - | - | $ 1.08 M | ||
|
CONMED Corporation
CNMD
|
648 M | $ 36.88 | 0.6 % | $ 1.14 B | ||
|
Integer Holdings Corporation
ITGR
|
279 M | $ 83.86 | -5.25 % | $ 2.91 B | ||
|
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 84.39 | 1.07 % | $ 49.4 B | ||
|
LENSAR
LNSR
|
32.6 M | $ 5.73 | 9.56 % | $ 68.5 M | ||
|
Pulmonx Corporation
LUNG
|
121 M | $ 1.37 | 6.64 % | $ 55.7 M | ||
|
MiMedx Group
MDXG
|
277 M | $ 3.64 | 8.33 % | $ 538 M | ||
|
Myomo
MYO
|
41.3 M | $ 0.91 | 5.28 % | $ 38.1 M |